We report a 23% asymptomatic severe acute respiratory syndrome
coronavirus 2 (SARS CoV-2) Omicron carriage rate in
participants being enrolled into a clinical trial in South Africa,
15-fold higher than in trials before Omicron. We also found
lower CD4 + T-cell counts in persons with human immunodeficiency
virus (HIV) strongly correlated with increased odds of
being SARS-CoV-2 polymerase chain reaction (PCR) positive.